Friday, March 29, 2024
News

Exploring RNAi and nanotechnology for cancer therapeutics: CSIR study

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | January 21, 2022 10:50:39 AM IST
Cancer is one of the leading causes of death worldwide and is attached to economic burden and social stigma. The quest to find plausible therapeutic interventions to replace non-specific chemo drugs has recently led to the development of novel strategies to combat cancer.

RNA interference (RNAi), a gene silencing approach, is a promising tool for targeted and focused therapy for chronic diseases like cancer. The lack of safe and effective delivery methods for RNAi molecules is one of the key challenges against using RNAi-based therapy in biological systems.

Dr. Lekha Dinesh Kumar and her group at CSIR-CCMB, in collaboration with the Polymer Science and Engineering Division at CSIR-NCL, have developed nano-curcumin structures (derived from turmeric) to encapsulate the RNAi (Ephb4 shRNA) and other molecules that aid in targeting specific tissues.

The proposed bio-drug is non-toxic, bio-compatible with a higher uptake efficiency, and shows effective site-specific delivery with regression of tumors in two different mouse models of colon and breast cancer.

"The use of curcumin, a well-known nutraceutical with high anti-cancer and anti-inflammatory properties with RNAi showed tumor retardation with six months survival in aggressive models of colon and breast cancer," said Dr. Kumar. This work has been published in the journal Nanoscale.

In another study with the School of Nanosciences, Central University Gujarat and Centre for Advanced Materials and Industrial Chemistry, RMIT Australia, they designed an eco-friendly and pH-responsive dietary fiber inulin-based nanodevice to target colon cancer.

This device suggests the possibility of substituting synthetic substances with natural compounds in bio-drug formulations for better bio-degradability, tissue accumulation, and lesser toxicity. The results from this work have been published in the journal Nanomedicine.

Dr. Kumar said, "In our studies, we have demonstrated that RNAi combined with appropriate targeting agents and encapsulations made of natural biomaterials have high translational capacity in mice models of cancer. This group of bio-drugs can revolutionize the field of cancer therapeutics in the future. It should be assessed in other cancer model systems to bring out the utility of these therapeutics in the clinical trials." (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE SCIENCE NEWS
AI technique accurately predicts deadly ...
Researchers discover new approach to tre...
Researchers discover how gene mutation r...
Climate change disrupts vital ecosystems...
Study finds how ageing reduces ability o...
Israeli researchers uncover biological p...
More...
 
INDIA WORLD ASIA
'Three parties have allied directly...':...
Eknath Shinde's Shiv Sena releases first...
Jailed gangster-turned-politician Mukhta...
Chennai: Three dead after false ceiling ...
Uttar Pradesh: Security tightened in Ali...
AAP workers protesting against Kejriwal'...
More...    
 
 Top Stories
8 people killed after pickup truck ... 
IPL 2024: Rishabh Pant feels 'disap... 
Eknath Shinde's Shiv Sena releases ... 
"Thought we could win series": Craw... 
"There's no one better in India to ... 
Jailed gangster-turned-politician M... 
Chennai: Three dead after false cei... 
I-League: Aizawl blank Churchill, c...